Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging markets
Simon Berry
ColaLife is a charity registered in the UK
Charity number: 1142516
• Small, independent and catalytic
• Focus on saving ch...
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Coca-Cola gets to most places, life-saving medicines don’t
Under 5 mortality is unacceptably high…
…when compared with more developed countries
Diarrhoea is the second biggest killer
Diarrhoea
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Sep 2010 | Enrolled into the J&J Innovation Bootcamp
Kris Pintens
Michelle Akande
Johan Offermans
Jane Berry
Alexander Bie...
Some of the ColaLife funders
Isenberg Family
Charitable Foundation
Awards | The Kit Yamoyo has won many global awards
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Dec 2011
The trial timeline
Mimicking Coca-Cola – creating a product people WANT
What we learnt
Litre sachets are too big
Measuring water was an issue...
Kit Yamoyo
• Attractive
• Affordable
• Packaging is also:
• A measuring device for
the water
• A mixing device
• A storage...
Kit Yamoyo – why the funny shape?
Mimicking Coca-Cola – Community-based marketing
0Nobody sold ORS
or Zinc in the
private sector.
Stock-outs in the
public sector were
common.
0Nobody sold ORS
or Zinc in the
private sector.
Stock-outs in the
public sector were
common.
<1%of children
received the
c...
0Nobody sold ORS
or Zinc in the
private sector.
Stock-outs in the
public sector were
common.
<1%of children
received the
c...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
60%Only 60% of
mothers mixed
ORS correctly
when given
1 litre sachets.
0Nobody sold ORS
or Zinc in the
private sector.
Sto...
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Manufacture
Assembly
Distribution
Wholesale
K3.10
Retail
K3.70
Customer
K5.00
Demand PULLED the Kit Yamoyo into rural comm...
What we learned (1)
1. Value chain
• Perceived value
• Delivers to expectations (use of standards)
• Product design
• Attr...
What we learned (2)
3. Behaviour change works better with a product
4. Organisations already exist but may need:
• Bringin...
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Ways to understand and improve Access
Various Access models (eg WHO/UNICEF) consider 4 or 5 facets of
Access, including:
•...
Insights for Janssen? - A wider view of Access?
Access considerations might usefully be expanded:
1. Asking the customer
•...
Our starting point
Management Board Update, Janssen, Beerse, Belgium
ColaLife learning and opportunities in emerging marke...
Our partnership – possible next steps
1. It’s about partnership for global impact (not funding)
2. Sharing our learning to...
Questions?
Comments?
ColaLife Presentation to the Janssen Management Board, 26-Aug-15
Upcoming SlideShare
Loading in …5
×

ColaLife Presentation to the Janssen Management Board, 26-Aug-15

331 views

Published on

A update on ColaLife activities for the Janssen Management Board including a discussion on opportunities for emerging markets.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

ColaLife Presentation to the Janssen Management Board, 26-Aug-15

  1. 1. Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets Simon Berry
  2. 2. ColaLife is a charity registered in the UK Charity number: 1142516 • Small, independent and catalytic • Focus on saving children’s lives • Looking for global impact through • Innovation • Generating robust evidence • Sharing findings and learning • Influencing healthcare strategies • No commercial interest 2009 2010 2011 2012 20131985 What is ColaLife and who am I?
  3. 3. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  4. 4. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  5. 5. Coca-Cola gets to most places, life-saving medicines don’t
  6. 6. Under 5 mortality is unacceptably high…
  7. 7. …when compared with more developed countries
  8. 8. Diarrhoea is the second biggest killer Diarrhoea
  9. 9. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  10. 10. Sep 2010 | Enrolled into the J&J Innovation Bootcamp Kris Pintens Michelle Akande Johan Offermans Jane Berry Alexander Bielders Simon Berry
  11. 11. Some of the ColaLife funders Isenberg Family Charitable Foundation
  12. 12. Awards | The Kit Yamoyo has won many global awards
  13. 13. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  14. 14. Dec 2011 The trial timeline
  15. 15. Mimicking Coca-Cola – creating a product people WANT What we learnt Litre sachets are too big Measuring water was an issue Willingness to pay Preferred branding
  16. 16. Kit Yamoyo • Attractive • Affordable • Packaging is also: • A measuring device for the water • A mixing device • A storage device (the soap tray is a lid) • A cup • And can be re-used
  17. 17. Kit Yamoyo – why the funny shape?
  18. 18. Mimicking Coca-Cola – Community-based marketing
  19. 19. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common.
  20. 20. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea
  21. 21. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS.
  22. 22. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS.
  23. 23. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS.
  24. 24. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS. >26k kits sold into the two remote rural trial areas in 12 months.
  25. 25. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS. >26k kits sold into the two remote rural trial areas in 12 months. 45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
  26. 26. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS. >26k kits sold into the two remote rural trial areas in 12 months. 45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%. 2.4km The distance to ORS/Zinc in the trial areas was reduced by two- thirds from 7.3km to 2.4km.
  27. 27. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS. >26k kits sold into the two remote rural trial areas in 12 months. 45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%. 2.4km The distance to ORS/Zinc in the trial areas was reduced by two- thirds from 7.3km to 2.4km. 93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
  28. 28. 60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets. 0Nobody sold ORS or Zinc in the private sector. Stock-outs in the public sector were common. <1%of children received the correct treatment for diarrhoea 7.3km Was the average distance to ORS. >26k kits sold into the two remote rural trial areas in 12 months. 45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%. 2.4km The distance to ORS/Zinc in the trial areas was reduced by two- thirds from 7.3km to 2.4km. 93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
  29. 29. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  30. 30. Manufacture Assembly Distribution Wholesale K3.10 Retail K3.70 Customer K5.00 Demand PULLED the Kit Yamoyo into rural communities
  31. 31. What we learned (1) 1. Value chain • Perceived value • Delivers to expectations (use of standards) • Product design • Attractive • Aspirational • Affordable • Profitable for all 2. Sensible use of subsidy • Top-end subsidy (non-corruption of the value chain) • Use of vouchers
  32. 32. What we learned (2) 3. Behaviour change works better with a product 4. Organisations already exist but may need: • Bringing together in new ways • Capacity building 5. Partnership and shared risk • Donor support for trials and start-up • Donor support for awareness raising and training • Private sector for sustainable production 6. Think about multi-channels to market • Are the private sector needs different from the public sector needs?
  33. 33. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  34. 34. Ways to understand and improve Access Various Access models (eg WHO/UNICEF) consider 4 or 5 facets of Access, including: • Availability • Accessibility • Acceptability • Affordability • Adherence
  35. 35. Insights for Janssen? - A wider view of Access? Access considerations might usefully be expanded: 1. Asking the customer • Review products destined for African market • Find out what people WANT not on what you think they NEED 2. Adapting better to the local context • Insights from working more closely with NGOs, local private sector 3. Advocacy with government, regulators, pharmacists 4. Deliver Advantage • All along the value chain – ‘price minus costing’ not ‘cost plus pricing’ 5. Awareness-raising • Not just advertising • Invest in customer education, retailer or wholesaler training 6. Aspiration • Produce products that people aspire to use • The poor are as brand and quality aware as anybody else
  36. 36. Our starting point Management Board Update, Janssen, Beerse, Belgium ColaLife learning and opportunities in emerging markets 26-Aug-15 Implications for Janssen Our partnership so far What we did Our partnership next stepsWhat we learned 3 5 6 1 4 2
  37. 37. Our partnership – possible next steps 1. It’s about partnership for global impact (not funding) 2. Sharing our learning to impact on the way Janssen does business in Africa (open access with support from ColaLife) 3. Use ColaLife as a catalyst for change • The grain in the oyster / the yeast in the bread 4. For this to work ColaLife would need a point of contact with the Management Board and Global Health Team
  38. 38. Questions? Comments?

×